NOTCH2 is neither rearranged nor mutated in t(1;19) positive oligodendrogliomas

PLoS ONE

Volumn 4, Issue 1, 2009, Pages

  Benetkiewicz, Magdalena ^a,b   Idbaih, Ahmed ^c,d   Cousin, Pierre Yves ^a,b   Boisselier, Blandine ^c,d   Marie, Yannick ^c,d   Crinière, Emmanuelle ^c,d   Hoang Xuan, Khê ^c,d   Delattre, Jean Yves ^c,d   Sanson, Marc ^c,d   Delattre, Oliver ^a,b  

^a INSERM   (France)

^b INSTITUT CURIE   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BREAKPOINT CLUSTER REGION PROTEIN; NOTCH2 RECEPTOR; TUMOR SUPPRESSOR PROTEIN; NOTCH2 PROTEIN, HUMAN;

ARTICLE; CENTROMERE; CHROMOSOME 1P; CHROMOSOME 9Q; CHROMOSOME DELETION; CHROMOSOME MAP; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 1; COMPARATIVE GENOMIC HYBRIDIZATION; DNA MICROARRAY; GENE DELETION; GENE INACTIVATION; GENE STRUCTURE; HUMAN; HUMAN TISSUE; MOLECULAR PROBE; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIOMA; POINT MUTATION; SEQUENCE HOMOLOGY; BRAIN TUMOR; CHROMOSOME 1; CHROMOSOME 19; GENE REARRANGEMENT; GENE TRANSLOCATION; GENETICS; METABOLISM; MOLECULAR GENETICS; MUTATION;

BASE SEQUENCE; BRAIN NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 19; DNA MUTATIONAL ANALYSIS; GENE REARRANGEMENT; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; OLIGODENDROGLIOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTOR, NOTCH2; TRANSLOCATION, GENETIC;

EID: 58149462265     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004107     Document Type: Article

References (36)

1. Kitange G, Misra A, Law M, Passe S, Kollmeyer TM, et al. (2005) Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomas. Genes Chromosomes Cancer 42: 68-77.
2. Smith JS, Alderete B, Minn Y, Borell TJ, Perry A, et al. (1999) Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Oncogene 18: 4144-4152.
3. Bigner SH, Matthews MR, Rasheed BK, Wiltshire RN, Friedman HS, et al. (1999) Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization. Am J Pathol 155: 375-386.
4. Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, et al. (1998) Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90: 1473-1479.
5. Kraus JA, Koopmann J, Kaskel P, Maintz D, Brandner S, et al. (1995) Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropathol Exp Neurol 54: 91-95.
6. Hoang-Xuan K, He J, Huguet S, Mokhtari K, Marie Y, et al. (2001) Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression. Neurology 57: 1278-1281.
7. Jeuken JW, von Deimling A, Wesseling P (2004) Molecular pathogenesis of oligodendroglial tumors. J Neurooncol 70: 161-181.
8. Okamoto Y, Di Patre PL, Burkhard C, Horstmann S, Jourde B, et al. (2004) Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas. Acta Neuropathol 108: 49-56.
9. Reifenberger G, Louis DN (2003) Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology. J Neuropathol Exp Neurol 62: 111-126.
10. Smith JS, Perry A, Borell TJ, Lee HK, O'Fallon J, et al. (2000) Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 18: 636-645.
11. Idbaih A, Marie Y, Pierron G, Brennetot C, Hoang-Xuan K, et al. (2005) Two types of chromosome 1p losses with opposite significance in gliomas. Ann Neurol 58: 483-487.
12. Abrey LE, Childs BH, Paleologos N, Kaminer L, Rosenfeld S, et al. (2006) High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: long-term follow-up. Neuro Oncol 8: 183-188.
13. Idbaih A, Marie Y, Lucchesi C, Pierron G, Manie E, et al. (2008) BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas. Int J Cancer 122: 1778-1786.
14. Jenkins RB, Blair H, Ballman KV, Giannini C, Arusell RM, et al. (2006) A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma. Cancer Res 66: 9852-9861.
15. Griffin CA, Burger P, Morsberger L, Yonescu R, Swierczynski S, et al. (2006) Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss. J Neuropathol Exp Neurol 65: 988-994.
16. Boulay JL, Miserez AR, Zweifel C, Sivasankaran B, Kana V, et al. (2007) Loss of NOTCH2 positively predicts survival in subgroups of human glial brain tumors. PLoS ONE 2: e576.
17. Hu QD, Ang BT, Karsak M, Hu WP, Cui XY, et al. (2003) F3/contactin acts as a functional ligand for Notch during oligodendrocyte maturation. Cell 115: 163-175.
18. Fan X, Mikolaenko I, Elhassan I, Ni X, Wang Y, et al. (2004) Notch1 and notch2 have opposite effects on embryonal brain tumor growth. Cancer Res 64: 7787-7793.
19. Locke DP, Segraves R, Nicholls RD, Schwartz S, Pinkel D, et al. (2004) BAC microarray analysis of 15q11-q13 rearrangements and the impact of segmental duplications. J Med Genet 41: 175-182.
20. Gregory SG, Barlow KF, McLay KE, Kaul R, Swarbreck D, et al. (2006) The DNA sequence and biological annotation of human chromosome 1. Nature 441: 315-321.
21. Grimwood J, Gordon LA, Olsen A, Terry A, Schmutz J, et al. (2004) The DNA sequence and biology of human chromosome 19. Nature 428: 529-535.
22. She X, Horvath JE, Jiang Z, Liu G, Furey TS, et al. (2004) The structure and evolution of centromeric transition regions within the human genome. Nature 430: 857-864.
23. Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M (2005) Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Clin Cancer Res 11: 1119-1128.
24. Nigro JM, Takahashi MA, Ginzinger DG, Law M, Passe S, et al. (2001) Detection of 1p and 19q loss in oligodendroglioma by quantitative microsatellite analysis, a real-time quantitative polymerase chain reaction assay. Am J Pathol 158: 1253-1262.
25. Baldini A, Smith DI, Rocchi M, Miller OJ, Miller DA (1989) A human alphoid DNA clone from the EcoRI dimeric family: genomic and internal organization and chromosomal assignment. Genomics 5: 822-828.
26. Gravholt CH, Friedrich U, Caprani M, Jorgensen AL (1992) Breakpoints in Robertsonian translocations are localized to satellite III DNA by fluorescence in situ hybridization. Genomics 14: 924-930.
27. Diaz-Castanos L, Rivera H, Perez-Garcia G, Dos Santos E, Malet P (1997) A further whole arm 1;19 translocation with alpha-satellite DNA breakage. Genet Couns 8: 33-38.
28. Blanco B, Loeza F, Carnevale A (1994) Balanced reciprocal whole arm translocation t(3;9): analysis by fluorescence in situ hybridisation. J Med Genet 31: 74-75.
29. Al-Taie OH, Seufert J, Mork H, Treis H, Mentrup B, et al. (2002) A complex DNA-repeat structure within the Selenoprotein P promoter contains a functionally relevant polymorphism and is genetically unstable under conditions of mismatch repair deficiency. Eur J Hum Genet 10: 499-504.
30. Ehrlich M (2002) DNA hypomethylation, cancer, the immunodeficiency, centromeric region instability, facial anomalies syndrome and chromosomal rearrangements. J Nutr 132: 2424S-2429S.
31. Cadieux B, Ching TT, VandenBerg SR, Costello JF (2006) Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation. Cancer Res 66: 8469-8476.
32. Fanelli M, Caprodossi S, Ricci-Vitiani L, Porcellini A, Tomassoni-Ardori F, et al. (2008) Loss of pericentromeric DNA methylation pattern in human glioblastoma is associated with altered DNA methyltransferases expression and involves the stem cell compartment. Oncogene 27: 358-365.
33. Sawyer JR, Tricot G, Mattox S, Jagannath S, Barlogie B (1998) Jumping translocations of chromosome 1q in multiple myeloma: evidence for a mechanism involving decondensation of pericentromeric heterochromatin. Blood 91: 1732-1741.
34. Wong N, Lam WC, Lai PB, Pang E, Lau WY, et al. (2001) Hypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma. Am J Pathol 159: 465-471.
35. Tsuda H, Takarabe T, Kanai Y, Fukutomi T, Hirohashi S (2002) Correlation of DNA hypomethylation at pericentromeric heterochromatin regions of chromosomes 16 and 1 with histological features and chromosomal abnormalities of human breast carcinomas. Am J Pathol 161: 859-866.
36. Ehrlich M, Hopkins NE, Jiang G, Dome JS, Yu MC, et al. (2003) Satellite DNA hypomethylation in karyotyped Wilms tumors. Cancer Genet Cytogenet 141: 97-105.